-

Nation’s PFAS Testing Leader, Eurofins Environment Testing USA, One of the First Commercial Laboratories to receive Accreditation for Draft Method 1633

LUXEMBOURG--(BUSINESS WIRE)--Eurofins (Paris:ERF):

Eurofins Environment Testing laboratories in Sacramento, CA and Lancaster, PA announce that they have received accreditation for Draft EPA Method 1633 for the US Department of Defense under QSM 5.4 Table B-24 for all 40 PFAS compounds for water, solids and tissue matrices. These laboratories are some of the first commercial laboratories to receive this accreditation, further exemplifying the Eurofins network of laboratories as a leader in PFAS testing.

With 15 years of experience, Eurofins Environment Testing USA laboratories utilize gold-standard methods to support PFAS analysis and analyze an extensive list of matrices for PFAS contamination. This list includes, but is not limited to: potable and non-potable water; solids and biosolids; powders and micro-powders; AFFF; concrete; dispersants; leachate; biota, tissue and vegetation; soils, sediments, and sludge; viscous liquids; commercial products such as carpeting, packaging and other items; foods and dairy; and animal and human serum and whole blood. Eurofins Environment Testing USA supports emerging technologies such as Total Oxidizable Precursors (TOP) Assay, TOF/AOF/EOF, and Non-Target Analysis.

About Eurofins Environment Testing – USA

Operating 42 Environmental Testing Laboratories, multiple service centres and employing 3,000 staff, the Eurofins Environment Testing network in the US contributes to a clean and safe environment by providing market-leading laboratory testing, monitoring and consulting services to a wide range of industrial companies, environmental consultants, contractors, retailers and government authorities. With a keen focus on client service, regulatory compliance and defensible data, the Eurofins environmental laboratories network performs analysis of drinking water, groundwater, seawater, soil, air, and tissue using state-of-the-art analytical methods to assess quality and impact on health and the environment.

About Eurofins – the global leader in bio-analysis

Eurofins is Testing for Life. With 58,000 staff across a network of 900 laboratories in 54 countries, Eurofins’ companies offer a portfolio of over 200,000 analytical methods.

Eurofins Shares are listed on Euronext Paris Stock Exchange.

Contacts

For further information:
Brooke Maharg
ir@eurofins.com

Eurofins

BOURSE:ERF

Release Versions

Contacts

For further information:
Brooke Maharg
ir@eurofins.com

More News From Eurofins

Eurofins MET Laboratories Opens New Safety, EMC, Wireless, and Renewable Energy Laboratory in the Boston Tech Corridor

BOSTON--(BUSINESS WIRE)--Eurofins MET Laboratories, part of the Eurofins Electrical & Electronics global network, announces the opening of its new state-of-the-art 60,000-square-foot testing laboratory in Littleton, Massachusetts – a prime location in the Boston innovation corridor. Positioned at the epicenter of New England's med-tech, wireless innovation, clean energy, and advanced electronics ecosystem, the capabilities of this laboratory further position Eurofins MET Laboratories as the...

Eurofins Scientific SE: Weekly Report on Share Repurchases from 26th January to 30th January 2026

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 26/01/2026 FR0014000MR3 5 000 70.7336 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 27/01/2026 FR0014000MR3 5 000 70.9680 XPAR EUROFINS SCIENTIFIC 529900JEHFM47...

Eurofins Delivers FY 2025 Objectives with a 24% EPS Growth, Accelerating Organic Revenue Growth, Margin Expansion, and Higher Free Cash Flow and Confirms Its 2027 Objectives

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins (Paris:ERF) pre-publishes below its preliminary unaudited consolidated financial results for the year ending 31 December 2025, as described in the first paragraphA of the Business Review section of this press release. Financial highlights in FY 2025 Basic EPS8 grew 24% to €2.31 in 2025 vs €1.87 in 2024, driven by a strong operating performance and starting to reap the benefits from Eurofins five-year investment programme in its hub and spok...
Back to Newsroom